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For many pathogenic bacteria like Pseudomonas
aeruginosa heme is an essential source of iron. After
uptake, the heme molecule is degraded by heme oxygenases to yield iron, carbon monoxide, and biliverdin.
The heme oxygenase PigA is only induced under ironlimiting conditions and produces the unusual biliverdin
isomers IX␤ and IX␦. The gene for a second putative
heme oxygenase in P. aeruginosa, bphO, occurs in an
operon with the gene bphP encoding a bacterial phytochrome. Here we provide biochemical evidence that
bphO encodes for a second heme oxygenase in P. aeruginosa. HPLC, 1H, and 13C NMR studies indicate that
BphO is a “classic” heme oxygenase in that it produces
biliverdin IX␣. The data also suggest that the overall
fold of BphO is likely to be the same as that reported for
other ␣-hydroxylating heme oxygenases. Recombinant
BphO was shown to prefer ferredoxins or ascorbate as a
source of reducing equivalents in vitro and the ratelimiting step for the oxidation of heme to biliverdin is
the release of product. In eukaryotes, the release of
biliverdin is driven by biliverdin reductase, the subsequent enzyme in heme catabolism. Because P. aeruginosa lacks a biliverdin reductase homologue, data are
presented indicating an involvement of the bacterial
phytochrome BphP in biliverdin release from BphO and
possibly from PigA.

In the presence of a suitable electron donor the enzyme heme
oxygenase (HO,1 EC 1.14.99.3) catalyzes the oxidative degradation of heme to yield equimolar amounts of biliverdin (BV), iron,
and CO (see Fig. 1). In the well studied eukaryotic HOs, NADPH
and NADPH-cytochrome P450 reductase serve as the electron
donor (1, 2). Bacterial HOs have only recently been described,
and the HO from Corynebacterium diphtheriae (HmuO) was
among the first ones to be discovered (3). In C. diphtheriae the
HO reaction is utilized to release iron from heme under patho* This work was supported by the Emmy-Noether-Program of the
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genic (i.e. free-iron limiting) conditions (3). In fact, the breakdown
of heme to mine iron is thought to be the major function of HOs
from pathogenic organisms, thus allowing them to overcome the
low concentrations of free-iron necessary for successful colonization (infection). Their function in iron utilization has been shown
for HOs from several pathogenic bacteria, including Neisseria
meningitidis (HemO), Corynebacterium ulcerans (HmuO), and
Staphylococcus aureus (IsdG/I) (4 – 6). One of the most interesting
bacterial HOs was recently identified in the Gram-negative opportunistic pathogen Pseudomonas aeruginosa. The pigA gene,
originally identified in a screen for iron-regulated genes, was
shown to encode a protein with homology to the neisserial HOs
(7). The gene, which is part of a five-gene operon (pigA–E), is
under the control of the global iron regulator Fur (ferric uptake
regulator) and is only expressed under iron-limiting conditions
(8). Unlike all other eu- and prokaryotic HOs that regiospecifically cleave the ␣-meso carbon of heme, PigA targets the ␤- and
␦-meso carbons of the heme macrocycle (7) (Fig. 1). The unusual
production of ␤- and ␦-BV was shown to be due to an unusual
seating of the substrate heme in the active site pocket of PigA (9).
The purpose for the production of these BV isomers and their fate
in P. aeruginosa, however, is currently unknown. In addition to
their function in iron utilization bacterial HOs are also involved
in the first step of phycobilin biosynthesis. These linear tetrapyrrole molecules are precursors of the chromophores for the cyanobacterial light-harvesting phycobiliproteins and the photoreceptor phytochrome. Phytochromes are traditionally known as
biliprotein photoreceptors in plants but have recently also been
discovered in bacteria (10). Unlike plant and cyanobacterial phytochromes, which carry a phytochromobilin or phycocyanobilin
chromophore, bacteriophytochromes (BphPs) from non-photosynthetic prokaryotes have been shown to utilize a BV chromophore
(11). P. aeruginosa was among the first non-photosynthetic bacteria identified to harbor a gene encoding for a BphP. This bacteriophytochrome is a typical sensor kinase of a prokaryotic twocomponent signaling system. The bphP gene is located in an
operon downstream from a bphO gene, which encodes a putative
HO. So far, no gene encoding for the corresponding response
regulator has been identified in P. aeruginosa. Herein we present
the first biochemical and biophysical evidence that bphO encodes
for a functional HO that oxidizes heme to BV IX␣. Because
P. aeruginosa is the first known organism to encode two functional HOs, each capable of oxidizing heme to a different BV
isomer, their involvement in phytochrome chromophore biosynthesis has been investigated and will also be discussed.
EXPERIMENTAL PROCEDURES

Reagents
All chemicals, including glutathione-agarose, were purchased from
Sigma (Munich, Germany) and were American Chemical Society grade
or better. Restriction enzymes were from Invitrogen (Cleveland, OH).
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FIG. 1. Reactions catalyzed by P. aeruginosa heme oxygenases. Two types of bacterial HOs are known so far that show different
regiospecificities toward the cleavage of the heme macrocycle. Most HOs cleave the heme at the ␣-meso carbon position yielding biliverdin IX␣. The
only HO showing a different regiospecificity is PigA from P. aeruginosa, which oxidizes heme to ␤- and ␦-biliverdin.
MasterTaqTM was purchased from Eppendorf Scientific (Westbury,
NY). HPLC-grade acetone and 80% formic acid were purchased from
Fisher Scientific (Pittsburgh, PA). The expression vector pGEX-6P-1
and PreScissionTM protease were obtained from Amersham Biosciences.
Centricon-10 concentrator devices were purchased from Amicon (Beverly, MA). Cytochrome P450 reductase was from Merck Biosciences
(Bad Soden, Germany), all ferredoxins, ferredoxin-NADP⫹ oxidoreductase, and catalase were from Sigma.

Construction of Expression Vectors
P. aeruginosa PAO I pigA and bphO (PA4116) genes were amplified
from chromosomal DNA via polymerase chain reaction with a hot start
protocol using the following primers, which contained the indicated and
underlined restriction sites: pigABamHIfwd: 5⬘-CGGGATCCGATACCCTGGCCCCTGAATCC-3⬘, pigAXhoIrev: 5⬘-CCGCTCGAGTCAGGCGAAGGTACGCTCCAG-3⬘; bphOBamHIfwd: 5⬘-GCGGATCCATCTCCCCATCTCCATCGCCAGC-3⬘, bphOSmaIrev: 5⬘-TCCCCCGGGTCAGGCTTCGTCGAGAACCCATC-3⬘. The polymerase chain reaction products
were then cut with the indicated enzymes and inserted into similarly
restricted pGEX-6P-1. The integrity of the plasmid constructs was
verified by complete DNA sequence determination of the insert (Davis
Sequencing, Davis, CA). Both constructs placed the heme oxygenase
gene downstream of and in frame with the glutathione S-transferase
(GST) gene of Schistosoma japonicum under the control of a Ptac promoter. A recognition sequence for PreScission protease is located upstream of the cloned gene. Proteolytic cleavage yields the native protein
with a small N-terminal extension.

Expression and Purification
Expression and purification were performed according to instructions supplied by the manufacturer (Amersham Biosciences) and as

described before (12). Recombinant P. aeruginosa BphP was expressed
using a tet promoter-driven Strep-tag system (13) (IBA, Göttingen,
Germany). Details of the cloning and purification will be published
elsewhere.

Protein Determination
Protein concentration was determined by the Bradford method with
bovine serum albumin as a standard or by measuring the absorbance at
280 nm and using the calculated ⑀280 nm for each individual protein
(14, 15).

Spectrophotometric Analysis of Biliverdin Production
The formation of BV IX␣ was detected spectrophotometrically at 450
nm by converting it to bilirubin IX␣ (BR) using recombinant rat biliverdin reductase (BVR) (16). An aliquot of ⬃5 g of crude recombinant
rat BVR (expression clone was a gift of Dr. J. C. Lagarias, University of
California at Davis) was added to the purified BphO䡠BV complex in 25
mM HEPES-KOH, 100 mM KCl, 10% glycerol, pH 7.5, and the reaction
was started by adding an NADPH-regenerating system containing 6.5
mM glucose 6-phosphate, 0.82 mM NADP⫹, and 1.1 unit/ml glucose-6phosphate dehydrogenase.

Reconstitution of BphO with Heme
The BphO䡠heme complex was prepared according to protocols previously described for heme䡠heme oxygenase complexes (3, 17). Heme was
added to purified protein at a final ratio 3:1 heme:protein. Aliquots of
heme (1.0 –30 M) were added to the cuvette containing 10 M BphO
and to the reference cuvette at room temperature. Spectra were recorded 5 min after heme addition.
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FIG. 2. A, affinity purification of recombinant BphO. SDS-PAGE analysis of whole cell protein extracts before (lane 1) and after (lane 2) induction
with IPTG. Lane 3 shows GST-BphO after glutathione agarose affinity chromatography; lane 4, PreScission Protease cleaved GST-BphO; lane 5,
BphO after the second glutathione-agarose affinity chromatography; lane M, molecular mass standards. Numbers on the right indicate positions
of molecular weight markers. B, absorbance spectroscopy of purified BphO. Electronic absorption spectra of recombinant BphO expressed and
purified under aerobic conditions (solid line) and after addition of rat BVR (dashed line). The insert shows the BphO absorbance spectrum after
anaerobic expression and purification.

Determination of the Extinction Coefficient for
the BphO䡠heme Complex
The millimolar extinction coefficient at 409 nm for the BphO䡠heme
complex was determined using the pyridine hemochrome method (2,
18). The isolated BphO䡠heme complex was converted to a pyridine
hemochrome in a 500-l sample volume by the addition of 62.5 l
pyridine and 62.5 l of 0.5 N NaOH solution. The spectrum of the
oxidized pyridine hemochrome was recorded. An excess of dithionite
was added, and the spectrum of the reduced ferrous pyridine hemochrome was recorded. The spectrum of the reduced form minus the
spectrum of the oxidized form was calculated at 557 nm. The concentration of heme was determined from the extinction coefficient using an
⑀405 nm value of 34,530 M⫺1 cm⫺1.

Spectroscopic Characterization of the Catalytic Turnover
of the BphO䡠heme Complex
The BphO䡠heme complex (1:3) was prepared as described above and
applied to a hydroxylapatite column (0.5 ⫻ 1.0 cm) equilibrated with 10
mM potassium phosphate buffer (pH 7.4). The column was washed with
the same buffer, and the protein eluted in 200 mM potassium phosphate
buffer (pH 7.4). The fractions containing the BphO䡠heme complex were
dialyzed against 25 mM HEPES-KOH containing 100 mM KCl and 10%
glycerol (pH 7.5).
The standard assay (0.5-ml final volume) contained 10  M
BphO䡠heme, 0.15 mg/ml bovine serum albumin, 4.6 M ferredoxin
(Spinacea, Porphyra, and Clostridium), 0.025 unit/ml spinach ferredoxin-NADP⫹ oxidoreductase in 25 mM HEPES-KOH buffer (pH 7.5).
The reaction was started by addition of the NADPH-regenerating
system listed above. Spectral changes between 300 and 800 nm were
monitored for 30 min at 37 °C. Sodium ascorbate or Trolox (6hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was added to
a final concentration of 5 mM unless otherwise noted. The reaction in
the presence of human cytochrome P450 reductase (hCPR) was carried out as described previously by Wilks and Schmitt (3). When
appropriate, catalase from Aspergillus niger was added to reaction
cuvettes at a ratio of catalase:BphO䡠heme 0.5:1 immediately before
the addition of reductant.

HPLC Analysis of BphO Reaction Products
BphO/PigA assay mixtures were loaded onto a Waters (Milford, MA)
C18 Sep-Pak Light cartridge preconditioned as follows: 3-ml wash with

FIG. 3. Absorption difference spectra of heme binding to
BphO. Increasing amounts of heme (1–30 M) were added both to the
reference and sample cuvettes.

acetonitrile to wet the Sep-Pak, 3-ml wash with MilliQ water, and 3-ml
wash with 50 mM 4-methylmorpholine/glacial acetic acid (pH 7.7). After
the sample was loaded onto the Sep-Pak, it was washed with 3 ml of
4-methylmorpholine/glacial acetic acid (pH 7.7) followed by 3 ml of 0.1%
(v/v) trifluoroacetic acid. The tetrapyrroles were then eluted from the
Sep-Pak using 2 ml of 100% acetonitrile. The eluate was dried using a
Speed-Vac lyophilizer, and the dried samples were analyzed by HPLC.
Samples were first dissolved in 10 l of Me2SO and then diluted with
200 l of the HPLC mobile phase. Following brief centrifugation and
filtration through a 0.45-m polytetrafluoroethylene syringe filter,
bilins were resolved by reversed phase chromatography using an
Agilent Technologies 1100 liquid chromatograph. The HPLC column
used for all of the analyses was a 4.6- ⫻ 250-mm Phenomenex Ultracarb 5-m ODS20 analytical column with a 4.6- ⫻ 30-mm guard
column of the same material. The mobile phase consisted of acetone:20 mM formic acid (50:50 by volume), and the flow rate was 0.6
ml/min. Eluates were monitored at 650 and 380 nm using an Agilent
Technologies 1100 series diode array detector.
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FIG. 4. Spectroscopic characterization of the catalytic turnover of the BphO䡠heme complex in the presence of spinach ferredoxin.
A, catalytic turnover of BphO䡠heme in the presence of spinach Fd. The oxyferrous complex is formed immediately and degraded to ferric-BV. B,
same reaction as A but in the presence of catalase. The reaction is arrested at the oxyferrous complex stage. C, same reaction as B. After addition
of ascorbate the oxyferrous complex is further degraded to yield iron-free BV. D, catalytic turnover of BphO䡠heme in the presence of 5 mM sodium
ascorbate. Initial spectra are shown in dashes, final spectra in bold. Spectra during this conversion are light gray. The direction of spectral changes
are indicated by arrows.

NMR Spectroscopic Characterization of BphO
Preparation of BphO Reconstituted with 13C-Labeled Heme—13CLabeled ␦-aminolevulinic acids (ALAs) were used as biosynthetic precursors for the preparation of protoheme IX (heme). ␦-[5-13C]Aminolevulinic acid ([5-13C]ALA) and [1,2-13C]ALA were synthesized utilizing
methods described previously (19). Heme labeled with 13C was obtained
utilizing previously reported methodology (9, 20 –22) developed to take
advantage of the fact that the first committed precursor in heme biosynthesis is ALA (23). Thus, 13C-labeled heme, which was biosynthesized in Escherichia coli upon addition of suitably labeled ALA, was
trapped by simultaneously expressing rat liver outer mitochondrial
membrane cytochrome b5. The details of the biosynthetic protocol,
which entail the expression and purification of outer mitochondrial
membrane cytochrome b5 harboring 13C-labeled heme, have been presented previously (9, 20 –22). 13C-Labeled heme was extracted from
outer mitochondrial membrane cytochrome b5 as follows: pyridine (15
ml) was added to 2.5 ml of 1 mM outer mitochondrial membrane cytochrome b5 in phosphate buffer ( ⫽ 0.10, pH ⫽ 7.0). Slow addition of
chloroform, typically 10 –12 ml, resulted in the precipitation of the
polypeptide, while maintaining the pyridine hemochrome in the supernatant. The latter was subsequently separated from the denatured
polypeptide by centrifugation and then dried over anhydrous MgSO4.
The desiccant was removed by filtration, and the filtered pyridinechloroform solution was transferred to a round bottom flask, where it
was concentrated to dryness in a rotary evaporator. Finally, the solid
was redissolved in 1.5 ml of Me2SO. BphO was reconstituted with a
freshly prepared solution of 13C-labeled heme by titrating it into a 25-ml
solution of phosphate buffer ( ⫽ 0.10, pH ⫽ 7.0) containing ⬃2 mol of
BphO until the ratio A280/ASoret no longer changed. The resultant solution containing the reconstituted enzyme was incubated at 4 °C overnight, then purified by size exclusion chromatography with the aid of a

Sephadex G-50 column (90 ⫻ 2.6 cm inner diameter) equilibrated and
eluted with 10 mM phosphate buffer, pH 7.0 at 4 °C. Fractions containing pure protein were concentrated in Amicon centrifugal concentrators
to ⬃1 ml and then transferred to smaller Centricon concentrators to
exchange the protein into deuterated phosphate buffer, pH 7.0, not
corrected for the deuterium isotope effect.
NMR Spectroscopy—1H and 13C NMR spectra were acquired on a
Varian Unity Inova spectrometer operating at frequencies of 599.740
(1H) and 150.817 (13C) MHz, respectively. 1H spectra were referenced to
the residual water peak at 4.8 ppm, and 13C spectra were referenced to
an external solution of dioxane (60% v/v in D2O) at 66.66 ppm. Proton
spectra were acquired with pre-saturation of the residual water peak
over 10,000 data points, with a spectral width of 24 kHz, a 150-ms
acquisition time, a 200-ms relaxation delay, and 1024 scans. 13C spectra
were collected over 12,000 data points, with a spectral width of 60 kHz,
a 100-ms acquisition time, a 25-ms relaxation delay, and 400,000 scans.
HMQC spectra were typically acquired with spectral widths of 24 kHz
for 1H and 50 kHz for 13C and a 200-ms relaxation delay. HMQC spectra
obtained from samples containing BphO reconstituted with heme labeled at the methyl, propionate-␤, and vinyl-␤ carbons were acquired
with refocusing delays based on 1JCH ⫽ 140 Hz, whereas spectra obtained from BphO reconstituted with heme labeled at the meso carbons
were acquired with 1JCH ⫽ 180 Hz. Data were collected as an array of
2,000 ⫻ 128 points with 512 scans per t1 increment and processed by
zero filling once in t2 and twice in t1 to obtain an 8,000 ⫻ 8,000 matrix.
This was apodized with a 90°-shifted squared sine bell function and
Fourier transformed. Water-eliminated Fourier transform-NOESY (24,
25) spectra were acquired with 24 kHz in both dimensions, 2,000 data
points in t2, 256 increments in t1, 352 scans per t1 increment, and
(typically) a 40-ms mixing time. The data were processed by zero filling
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in both dimensions to obtain an 8,000 ⫻ 8,000 matrix, apodized with
90°-shifted squared sine bell, and Fourier transformed.

Gel Permeation Chromatography
An Amersham Biosciences Superdex 200 HR10/30 gel permeation
chromatography column was equilibrated in 50 mM TES-KOH buffer,
pH 7.5, containing 100 mM KCl and 10% (v/v) glycerol (GPC buffer) at
a flow rate of 0.4 ml/min. Standards with known Mr (i.e. ␤-amylase
200,000; alcohol dehydrogenase 150,000; bovine serum albumin 66,000;
carbonic anhydrase 29,000; and cytochrome c 12,600) were applied to
the column (100 g), and their elution volumes were determined spectroscopically at 280 nm. 10 M BphP and 10 M estimated BV (bound to
BphO) were applied to the column and chromatographed under conditions identical to those used for the standard proteins. All samples were
also monitored at 650 nm for BV detection.

Phytochrome Difference Spectroscopy
To test chromophore assembly of BphP in vitro, 20 M recombinant
apo-BphP was incubated with 40 M chromophore or BphO (PigA)䡠BV

FIG. 5. HPLC analysis of the reaction products of the two
P. aeruginosa heme oxygenases. Purified recombinant BphO and
PigA were assayed for HO activity. Bilins were extracted from the
incubation mixture using a SepPak C18 reversed phase cartridge and
analyzed by reversed phase HPLC as described under “Experimental
Procedures.” The HPLC solvent was acetone:20 mM formic acid (50:50,
v/v), and the eluate was monitored at 650 nm. The top trace shows the
metabolites obtained by the BphO reaction; the bottom trace shows the
products of the PigA reaction. Retention times for the four BV IX
isomers are indicated by arrows.
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complex for 30 min at room temperature in darkness. Absorbance
spectra were obtained after 3-min incubation with red light at 630 nm
(Pfr spectrum) and far red light at 750 nm (Pr spectrum), respectively, in
a volume of 500 l (50 mM HEPES-KOH, 20 mM KCl, pH 8.0) using an
Agilent Technologies 8453 Value Analysis UV-Visible System. Difference spectra (Pr ⫺ Pfr) were calculated.

Coupled Oxidation of Heme
The four isomers of BV IX were obtained through coupled oxidation
of heme in pyridine as described before (26). The four BV isomers were
separated using a semi-preparative reversed phase HPLC of the same
material as described above, except that the flow rate was 2 ml/min.
RESULTS

Expression and Purification of Recombinant P. aeruginosa
Heme Oxygenases—The P. aeruginosa pigA and bphO genes
were expressed using a tac promoter-driven N-terminal GST
fusion expression system. All the reported results were obtained for recombinant BphO unless otherwise noted. Recombinant PigA and BphO could be purified to ⬃99% homogeneity,
as shown in Fig. 2A for BphO. One single band was obtained on
SDS-PAGE migrating at ⬃23,000, which corresponds to the
predicted relative molecular weight calculated from the amino
acid composition (Mr ⫽ 21,465). One liter of bacterial culture
typically yielded 10 mg of purified BphO. Interestingly, expression of recombinant protein resulted in the development of a
bright green color (Fig. 2B as seen by absorption at 650 nm)
indicating the production of BV during the recombinant expression of BphO. The produced BV appears to have a high affinity
toward BphO, because the BphO䡠BV complex remained stable
throughout the entire purification process; however, the bound
BV can be replaced by the substrate heme (see below). The
production of BV was further confirmed by its conversion to
bilirubin (BR) upon addition of rat biliverdin reductase (BVR).
Hence, addition of BVR and NADPH to the purified BphO䡠BV
complex resulted in the conversion of the bound BV to BR,
which was accompanied by a color change from green to yellow
and by the appearance of a peak at 450 nm (Fig. 2B). For
additional confirmation that the production of BV was due to
the action of BphO during expression, BphO was expressed
under anaerobic culture conditions using nitrate as a terminal
electron acceptor. Because any known HO reaction is oxygendependent, no formation of BV should be obtained. As expected,
no color formation was observed during anaerobic expression

TABLE I
Tested reductants in the BphO assay

a
b

Reductant

Concentration

Ferredoxin spinach 关2Fe-2S兴
Ferredoxin Clostridium 关4Fe-4S兴
Ferredoxin Porphyra 关2Fe-2S兴
Sodium ascorbate
Trolox
H2O2
H2O2
H2O2
Catalase
Ferredoxin spinach
Ascorbate
Ferredoxin Clostridium
Ascorbate
Ferredoxin Porphyra
Ascorbate
Ferredoxin spinach
Trolox
Ferredoxin spinach
Catalase
Ascorbate (later)
Human cytochrome P450
reductase

4.6 M
4.6 M
4.6 M
5 mM
5 mM
30 M
300 M
300 M
4.6 M
5 mM
4.6 M
5 mM
4.6 M
5 mM
4.6 M
5 mM
4.6 M
5 M
5 mM
2.5 M

Visible intermediates
2⫹

Oxyferrous complex (Fe -O2) (545 nm, 579 nm)
Fe2⫹-O2 (545 nm, 579 nm)
Fe2⫹-O2 (545 nm, 579 nm)
BphO-heme complex degradation
NDb
ND
Fe3⫹-verdoheme

Final product

Ferric-biliverdin (Fe3⫹-BV)a
Fe3⫹-BV
Fe3⫹-BV
Fe3⫹-BV

ND
BphO-heme complex degradation

BV

BphO-heme complex degradation

BV

BphO-heme complex degradation

BV

BphO-heme complex degradation

BV

BV, biliverdin; Fe3⫹-BV, ferric-biliverdin; Fe2⫹-O2, oxyferrous complex.
ND, nothing detected.

Fe2⫹-O2
BV
ND

45796

Pseudomonas BphO-BphP

FIG. 6. Water-eliminated Fourier transform-NOESY (30 °C) spectrum of BphO-CN. Resonance assignments for heme substituents are
obtained by following the dipolar connectivities starting from meso-H␦ at 7.19 ppm and walking through the macrocycle in two directions: 1)
meso-H␦ 3 1Me 3 2V␤ 3 2V␣ 3 meso-H␣ 3 3Me 3 4V␤ 3 meso-H␤ 3 5Me 3 6P␣. The 4V␣ resonance can also be identified by its cross-peak
with 4V␤; 2) meso-H␦ 3 8Me 3 7P␣.

and purification, but the spectrum of purified recombinant
BphO showed a small peak around 420 nm suggesting the
formation of a BphO䡠heme complex (Fig. 2B, inset). These observations taken together demonstrated that recombinant
BphO is already active in E. coli, where it must interact with a
reducing agent. The nature of this reductant, however, remains
to be elucidated.
Heme Binds to BphO—The formation of a BphO䡠heme complex was determined by difference spectroscopy. To this end,
equal aliquots of hemin were added to the sample cuvette
containing the BV complex of BphO in buffer and to the reference cuvette containing only buffer. Addition of hemin to BphO
resulted in the replacement of BV, which was evident from a
change in color of the solution, from green to brownish red. The
electronic absorption spectrum of the BphO䡠heme complex is
different from that of the BphO䡠BV complex and from that of
free heme in solution (Fig. 3). The BphO䡠heme complex has a
Soret band at 409 nm, which is close to that reported for other
bacterial HO䡠heme complexes (27). Attempts to calculate the
dissociation constant (Kd) did not result in reliable data, which
is most likely a consequence of competition between BV and
hemin for the binding site in BphO. Efforts to remove the
relatively tightly bound BV from BphO prior to the titration
experiments failed. The extinction coefficient of the BphO䡠heme
complex was found to be 97.6 mM⫺1 cm⫺1, a value that appears
to be the lowest reported for a bacterial HO.
Spectroscopic Characterization of the Catalytic Turnover of
the BphO䡠heme Complex—The catalytic turnover of the ferric
BphO䡠heme complex in the presence of spinach ferredoxin and
a ferredoxin reductase system (i.e. ferredoxin-NADP⫹-oxidoreductase and a NADPH-regenerating system) was meas-

1

H and

13

TABLE II
C chemical shifts (ppm) from heme substituents in
cyanide-inhibited BphO at 30 °C
1

1Me
3Me
5Me
8Me
2V␣
2V␤
4V␣
4V␤
Meso-␣
Meso-␤
Meso-␥
Meso-␦
6P␣
6P␤
7P␣
7P␤

H

13

C

8.41
19.73
11.42
12.03
14.41
⫺4.40, ⫺5.17
15.31
⫺2.25, ⫺2.51
⫺1.35
8.00

⫺18.43
⫺45.17
⫺24.64
⫺28.91

7.19
8.04, 9.65
1.13, ⫺0.56
11.01, 7.31
⫺1.01, ⫺2.06

17.78

188.27
148.63
51.89
3.37

116.97
109.68

ured spectrophotometrically. In the presence of reduced spinach ferredoxin the BphO䡠heme complex was immediately
converted to the oxyferrous complex, which was accompanied
by a shift in the Soret band from 409 to 412 nm and by the
appearance of ␤/␣-bands at 545 and 579 nm, respectively (Fig.
4A). Within 30 min the oxyferrous complex was fully degraded
to ferric-BV (Fig. 4A). Interestingly, when the reaction mixture
contains the hydrogen peroxide scavenger catalase in addition
to Fd, to rule out non-enzymatic coupled oxidation of the
BphO䡠heme complex, the reaction proceeded much slower and
was arrested at the oxyferrous stage; the latter remained stable
over at least 30 min (Fig. 4B). Because it has been reported that
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FIG. 7. Downfield portion of the 1H
NMR spectra of cyanide inhibited
HemO (A), HmuO (B), PigA (C), and
BphO (D). The presence of only one heme
methyl resonance in this region, 3Me, is
diagnostic of all known ␣-hydroxylating
HOs, where the proximal histidine-imidazole plane lies approximately parallel to
the ␤-␦-meso axis (see Fig. 8). The same
region of the 1H NMR spectrum of PigA,
where the heme is rotated in-plane ⬃100°
relative to the ␣-biliverdin-producing
HOs, shows three heme methyl resonances. These resonances indicate that
the proximal histidine-imidazole plane in
PigA lies approximately parallel to the
␣-␥-meso axis (see Fig. 8).

for some bacterial HOs the Fd-dependent conversion of heme to
BV requires a second reductant such as ascorbate (28), ascorbate or Trolox was added to the arrested reaction. This resulted
in the full conversion of the oxyferrous complex to iron-free BV,
as was evident from the development of green color and from
the appearance of a peak at 680 nm (Fig. 4C). In comparison,
ascorbate by itself supported the oxidation of the BphO䡠heme
complex to ferric (Fe3⫹-) BV (Fig. 4D). Addition of catalase to
the ascorbate-mediated heme degradation did not alter the
reaction.
To distinguish the observed spectral changes from a coupled
oxidation reaction, the BphO䡠heme complex was incubated
with 30 or 300 M H2O2, respectively. Only the high concentration of H2O2 promoted the coupled oxidation reaction, which
resulted in the formation of Fe3⫹-verdoheme (Table I). If the
same reaction also contained catalase, no heme degradation
was observed, which confirmed that in the presence of peroxides heme in the BphO䡠heme complex was degraded via coupled
oxidation.
Reductant Specificity of BphO—The reductant specificity of
BphO was tested using several commercially available reductants in our assay system. We tested the Fds from Clostridium
sp. [4Fe-4S], Porphyra sp. [2Fe-2S], together with spinach

ferredoxin-NADP⫹ oxidoreductase as well as human cytochrome P450 reductase (hCPR). All Fds tested were capable of
supporting the degradation of the BphO䡠heme complex,
whereas hCPR failed to mediate the oxidation of the
BphO䡠heme complex. Furthermore, sodium ascorbate was a
potent reducing partner (as described above). Experiments using a single reductant always resulted in the production of
ferric-BV. Only if a second reductant was present iron-free BV
was the final product. The results are summarized in Table I.
HPLC Analysis of the BphO and PigA Reaction Products—
Upon completion of the Fd-mediated degradation of the
BphO䡠heme complex, the reaction products were extracted using C18 SepPak cartridges and subsequently subjected to reverse phase HPLC. The four BV IX isomers were used as a
standard as well as the reaction products of the PigA reaction.
Fig. 5 shows a chromatogram confirming that BV IX␣ is the
only product of the BphO reaction, whereas PigA produces the
␤- and ␦-isomers of BV IX.
NMR Spectroscopic Characterization of BphO—Chemical
shifts for 1H and 13C nuclei originating from heme methyl and
meso positions of cyanide-inhibited BphO (BphO-CN) were
identified with a combination of one-dimensional non-decoupled 13C and HMQC spectra, according to the assignment
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FIG. 8. Plot illustrating the dependence of the heme methyl chemical shifts on the angle  made by the projection of the proximal
histidine-imidazole plane and the molecular x-axis (32, 49). In all ␣-biliverdin-producing HOs, including BphO, the proximal histidineimidazole plane lies nearly parallel to the ␦-␤-meso axis (bottom right). The order and position of the heme methyl chemical shifts in BphO indicate
that the angle  in this enzyme is ⬃133° (see plot), a value very similar to that seen in the crystal structures of HmuO (37), HemO (36), and HO-1
(33). The heme methyl chemical shifts of PigA have been used to predict (9) that its heme is rotated in-plane nearly 100° (top right) so that the
proximal histidine-imidazole plane lies nearly parallel to the ␣-␥-meso axis and forms an angle  of ⬃35°. This prediction was corroborated in the
recent crystal structure of PigA (34).

strategies outlined in previous work (9, 21, 22). The 1H resonance assignments corresponding to heme substituents were
subsequently obtained from the NOESY map shown in Fig. 6.
The significance of these assignments (summarized in Table II)
is presented below.
It has been proposed that the pattern of paramagnetically
affected heme methyl resonances in the 1H NMR spectra of HO
enzymes is diagnostic of the heme in-plane orientation, and
hence regioselectivity of meso carbon oxidation (9, 21). For
instance, the cyanide-inhibited forms of ␣-biliverdin-producing
HO enzymes (HO-CN) exhibit 1H NMR spectra with only 1
heme methyl resonance above 12 ppm (3Me). Fig. 7 (A and B)
illustrates the downfield portion of the 1H NMR spectra of the
␣-biliverdin producing HmuO-CN and HemO-CN, respectively,
with only the 3Me resonance from its major (3Me) and minor
(3me) heme orientational isomer resolved from the diamagnetic
envelope of resonances (21, 29). The spectra of the ␣-biliverdinproducing human and rat HO-1-CN enzymes are essentially
identical to those shown in Fig. 7 (A and B) (30, 31). In comparison, the 1H NMR spectrum of PigA-CN, where the heme is
rotated in-plane ⬃100° relative to the heme of the ␣-biliverdinproducing enzymes, exhibits three heme methyl resonances
from the more abundant heme orientational isomer (5Me, 1Me,
and 8Me) and three from the less abundant isomer (me) (9) (see
Fig. 7C). It is therefore evident from the resolved portion of the
1
H NMR spectrum of BphO䡠CN (Fig. 7D), which only displays
the methyl resonance corresponding to 3Me, that this enzyme
should oxidize heme to produce ␣-biliverdin. Indeed, this prediction based on the diagnostic feature of the downfield resolved 1H NMR spectrum is in good agreement with the fact

that assays of heme oxidation regio-selectivity yield only
␣-biliverdin.
The plot shown in Fig. 8 permits a straightforward correlation of the observed shifts for the four heme methyl groups as
a function of the angle  formed between the axial histidineimidazole plane and the molecular x-axis (32). Interpretation of
the heme methyl resonance assignments in the context of this
plot made it possible to correctly predict an angle  of 125° for
the proximal imidazole of human heme oxygenase (32) before
the x-ray crystal structure was solved (33). Moreover, interpretation of the heme methyl resonances from PigA in the context
of the plot of Fig. 8 also made it possible to predict (9) that the
heme in this enzyme is rotated in-plane ⬃110° relative to the
heme in ␣-biliverdin HO enzymes before the x-ray crystal
structure of PigA (34) confirmed this prediction. Hence, the
order of the heme methyl resonances, 3Me ⬎ 8Me ⬎ 5Me ⬎
1Me (see Table II) suggests that the proximal histidine-imidazole plane in BphO forms an angle of ⬃133° with respect to the
molecular x-axis, as defined in Fig. 8. This indicates that the
proximal histidine-imidazole plane in BphO lies almost parallel to the ␤-␦-meso axis (shown schematically in Fig. 8) as is the
case for all ␣-biliverdin producing HOs whose structure is
known (human (33) and rat (35) HO-1, HemO (36), and HmuO
(37)).
Interaction between HO䡠BV Complexes and BphP—It has
been mentioned above that recombinant BphO purifies as a
stable BphO䡠BV complex. The bound BV cannot be removed by
gel filtration, ion exchange chromatography, or changes in solution pH, indicating that the release of the BV product is
probably the rate-limiting step in this reaction and that BV has
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FIG. 9. Characterization of the interaction between HO䡠BV complexes with BphP. A, absorbance spectra of purified BphO䡠BV (dashed
line), apo-BphP (dotted line), and a 1:1 mixture of both (solid line). The inset shows an enlargement of the region between 500 and 800 nm. B, redand far-red light-induced difference spectroscopy of the 1:1 mixture of BphO䡠BV and apo-BphP. C, gel permeation chromatography of BphO and
BphP using a Superdex 200 column. Absorbance values were monitored at 280 nm (protein; solid lines) and 650 nm (BV; dashed lines). Upper
chromatogram, BphP; second chromatogram, BphO䡠BV; lower chromatogram, 1:1 mixture of BphP and BphO䡠BV. D, red- and far-red light-induced
difference spectroscopy of the 1:1 mixture of PigA䡠BV and apo-BphP.

a high affinity toward BphO. The release of BV is known to be
the rate-limiting step in other HOs. In the case of mammalian
HOs the rate limitation is overcome by the presence of BVR,
the subsequent enzyme in heme catabolism; the presence of
BVR accelerates the release of BV (38). Because P. aeruginosa
lacks a BVR homologue, another enzyme might be involved in
the release of BV from BphO. Because the bphO gene is located
in an operon together with the gene bphP, which encodes a
bacterial phytochrome, we tested the interaction between recombinant BphO and BphP (a) to probe if BphO is able to
produce the chromophore for BphP and (b) to investigate if the
release of BV is facilitated through the interaction with BphP.
Hence, purified BphO䡠BV was incubated with purified apoBphP while monitoring changes in absorbance. The mixture
was subsequently subjected to red- and far-red light-induced
difference spectroscopy (39) to test for the formation of holoBphP. As shown in Fig. 9A the spectrum of BphO䡠BV changes
upon addition of BphP leading to the formation of a photoactive
holo-BphP (Fig. 9B). To further confirm that BphO and BphP
interact to transfer the BV produced by BphO to BphP, we
subjected both proteins to gel permeation chromatography
(GPC) to see whether we obtain any physical interaction between both proteins. As seen in Fig. 9C both proteins by themselves elute as single peaks on a Superdex 200 GPC column
(upper two elution profiles). Monitoring the absorbance values
at both 280 nm (protein) and 650 nm (BV) confirmed that BphO

forms a very stable complex with BV. After incubation of both
proteins in a 1:1 ratio and subsequent chromatography, we
were still able to separate both proteins from each other. However, a major portion of the absorbance at 650 nm (i.e. BV) was
then associated with BphP, indicating that BV was removed
from BphO and was attached to BphP. This attachment was
identified to be covalent by zinc blotting (40) (data not shown)
and is in agreement with other known bacterial phytochromes
that form a covalent complex with BV (11, 41). Experiments to
identify real physical interaction between BphO and BphP
using the GPC method after Hummel and Dreyer (42) with
BphO䡠BV in the mobile phase did not reveal a stable complex of
both proteins (data not shown).
Because PigA, the second HO in P. aeruginosa, also purifies
as a stable PigA䡠BV complex, similar experiments were performed using the PigA䡠BV complex. Incubation of PigA䡠BV with
BphP also resulted in an absorbance change yielding a functional holo-BphP (Fig. 9D). In contrast to BphO, which only
produced the ␣-isomer of BV IX, PigA produced two different
isomers of BV IX. Because the purified PigA䡠BV complex most
likely consisted of a mixture of PigA䡠BV IX␤ and PigA䡠BV IX␦,
it was necessary to establish which BV isomer is responsible for
the obtained photoactive phytochrome. Therefore, we obtained
each BV isomer through coupled oxidation of heme and tested
whether they are able to bind to apo-BphP. As shown in Fig. 10
only the BV isomers IX␣ and IX␦ are able to form a photoactive
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FIG. 10. Difference spectroscopy of BphP incubated with the
BV IX isomers produced by P. aeruginosa. A, BphP incubated with
BV IX␣; B, BphP incubated with BV IX␦; C, BphP incubated with BV
IXb.

holo-phytochrome. The ⌬⌬A of the obtained difference spectrum with BV IX␦ is ⬃one-fifth of that with BV IX␣ implying a
lower affinity of BV IX␦ toward BphP. Furthermore, it was
shown that both isomers (␣ and ␦) form a covalent bond with
BphP (data not shown). These results indicate that the obtained difference spectrum after incubation of PigA䡠BV with
BphP is due to the covalent attachment of BV IX␦ to BphP.
DISCUSSION

bphO Encodes a Second Heme Oxygenase in P. aeruginosa—
The Gram-negative opportunistic pathogen P. aeruginosa is
the first example of an organism that harbors two heme oxygenases with different regiospecificity of heme cleavage. The
PigA enzyme has already been well characterized and is known
to be involved in the mining of heme-iron under the free-iron
limiting conditions likely to occur during infection of a host cell
(7). On the basis of 1H NMR and resonance Raman studies, it
was recently determined that the unusual regiospecificity of
PigA is due to a rotated seating of the heme substrate in the

active site pocket (9). This observation was further confirmed
by the recently published crystal structure of PigA (34). The
biological reason for the production of BV IX␤ and BV IX␦,
however, remains unknown. In comparison, to date, there is
only indirect evidence that bphO genes encode for functional
HOs (11). In this report we present biochemical and biophysical
evidence demonstrating that recombinant P. aeruginosa BphO
is indeed a heme oxygenase that catalyzes the conversion of
heme to BV IX␣.
BphO Prefers Ferredoxins and Ascorbate as Reducing Partners—Most HOs are capable of utilizing an endogenous E. coli
electron donor, which is manifested as a green color in E. coli
cells expressing HOs (3, 27, 43). In vitro, however, the activity
of most bacterial HOs is usually tested using either mammalian CPR or ascorbate as an electron donor. E. coli possesses
several reductants that could possibly serve as electron donors;
among them are several Fds and flavodoxin (44). We therefore
tested commercially available Fds, as well as ascorbate, for
their ability to serve as electron donors for the P. aeruginosa
HOs. Indeed, we were able to show that reduced Fds can serve
as the electron donor in the BphO reaction, yielding ferric-BV
as the final product. In the presence of catalase the conversion
from heme to ferric-BV was arrested at the stage of the oxyferrous complex, suggesting that the conversion of the oxyferrous
complex to ferric-BV is partly due to coupled oxidation. Fd has
a sufficiently negative reduction potential to reduce O2 to superoxide (45); hydrogen peroxide is then spontaneously formed
through dismutation of the superoxide radical. The presence of
H2O2, which is known to react with FeII-heme to hydroxylate
the heme (46), is scavenged by the presence of catalase. Only
when a second reductant such as ascorbate is added to the
reaction mixture, is the oxyferrous complex oxidized to BV,
thus indicating that the reaction is catalyzed by BphO. The
requirement for a second reductant in addition to Fd is in
agreement with observations described for HO from algae,
plants, and cyanobacteria (28, 47). Interestingly, it has been
shown that the cyanobacterial HO-1 reaction is also terminated
at the oxyferrous complex stage with cytochrome P450 reductase (27) indicating that this is a stable intermediate and that
the following steps in the catalytic cycle might require a second
reductant. Alternatively, it is also possible that the true physiological reductant in P. aeruginosa is capable of supporting the
complete catalytic cycle. In contrast to other described bacterial
HOs, hCPR was unable to mediate the conversion of heme to
BV by BphO in our assay system, indicating that with regard to
the redox partner BphO is quite different from other bacterial
HOs and more similar to those described for cyanobacteria and
plants. In agreement with many other described HOs, ascorbate is also capable of serving as an electron donor in the BphO
reaction. Because catalase has no effect in the ascorbate-supported reaction, no coupled oxidation is involved during catalysis. Therefore it appears that ascorbate is the most efficient
reductant tested for the in vitro activity of BphO. The origins of
the endogenous reductant in E. coli and the one supporting the
activity in P. aeruginosa remain to be elucidated.
The Second HO in P. aeruginosa, BphO, is an ␣-Meso-hydoxylating Enzyme—PigA was initially reported to oxidize
heme to produce mostly ␤-biliverdin (7). Subsequent studies
established that PigA oxidizes heme to a mixture of ␤- (30%)
and ␦- (70%) biliverdin (9). Further, NMR spectroscopic studies
revealed that the heme in PigA is rotated in-plane ⬃100°
relative to the heme in all ␣-hydroxylating heme oxygenase
enzymes (9) (see Fig. 11A). This in-plane rotation locates the
␦-meso carbon within the fold of PigA in the same place where
␣-biliverdin forming HOs place the ␣-meso carbon (9) (see Fig.
11B). Hence, attack of the ␦-meso carbon in PigA leads to the
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FIG. 11. A, the in-plane heme orientation in PigA places the ␦-meso carbon within the fold where it is susceptible to oxidation. A 180° rotation
of the heme about the ␣-␥-meso carbon places the ␤-meso carbon where it is susceptible to oxidation (9, 34). B, the heme in ␣-biliverdin producing
HOs (HemO is used as an example (36)) places the ␣-meso carbon in a location equivalent to that of the ␦-meso carbon in PigA, thus resulting in
␣-meso carbon oxidation.

formation of 70% ␦-biliverdin. Inspection of Fig. 11A also reveals that a 180° rotation of the heme about the ␣-␥-meso axis,
a phenomenon common in heme proteins where the heme is not
covalently attached to the polypeptide (48), places the ␤-meso
carbon where it is attacked, thus explaining the formation of
30% ␤-biliverdin (9). More recently it has been shown that the
heme, in one of the heme orientational isomers of the R177E
mutant of C. diphtheriae HmuO, rotates ⬃85° and places the
␤-meso carbon in the place typically occupied by the ␣-meso
carbon, which results in the formation of ⬃50% ␤-biliverdin
(21). Results obtained from the NMR spectroscopic analysis of
BphO strongly suggest that the fold of BphO is likely very
similar to that of the other heme oxygenase enzymes. Moreover, these observations also imply that one of the most important structural differences between the two heme oxygenase
enzymes in P. aeruginosa is the in-plane conformation of the
heme, with the heme in PigA being rotated ⬃110° relative to
that of the heme in BphO. This different in-plane conformation
of the heme allows BphO to locate the ␣-meso carbon where it
can be hydroxylated by the FeIII-OOH intermediate.
Interaction between BphO and BphP Facilitates the Release
of BV from BphO—Single turnover experiments of human
HO-1 have revealed that the release of BV from HO-1 is the
rate-limiting step in the conversion from heme to BV (38). In
the presence of BVR, this step is accelerated and one of the
earlier electron transfer steps becomes rate-limiting. The data
presented here indicate that the bacterial phytochrome BphP
from P. aeruginosa whose gene is encoded in the same operon
as bphO is able to interact with the BphO䡠BV complex and
facilitates the release of BV. The BV is “pulled” out of the HO
and forms a stable covalent adduct with BphP, which was
confirmed by difference spectroscopy and zinc blotting. BphP is
not only able to use iron-free BV as a substrate (as shown with
purified BphO䡠BV complex) but also the Fe3⫹-BV, which is the
product of the Fd-mediated reaction (data not shown). These
results indicate that BphO produces the chromophore for the
bacterial phytochrome BphP and that the activity of BphO

might be regulated through the interaction between BphO and
BphP. The biological role of BphP still remains to be elucidated.
In addition to the BphO-BphP interaction, we were able to
show that BphP also facilitates the release of BV from PigA.
From reports by other groups it is known that an A-ring endo
vinyl-group of the BV is necessary for binding to BphP (41).
Therefore, only the BV IX␦ isomer should yield a photoactive
holo-BphP. Indeed, using the BV isomers obtained from a coupled oxidation reaction, we were able to show that only BV IX␦
binds to BphP. The attachment was shown to be covalent. This
indicates that the release of the bound BV from the HOs is
determined by the type of bound BV rather than by the nature
of the protein. Therefore, the holo-BphP obtained upon incubation of PigA䡠BV with BphP arises from the release of BV IX␦
from PigA. Because PigA in vitro produces the BV isomers in a
ratio of 30:70 (IX␤:IX␦) (9), BV IX␦ is a possible chromophore
for BphP, although the amount of resultant holo-BphP is only
one-fifth that of the BV IX␣-BphP adduct. This could be due to
a lower affinity of BV IX␦ toward BphP. Therefore, the function
of this photoactive phytochrome might be different from that
with bound BV IX␣. Although we were able to show in this
study that BphP is able to bind BV IX␦, its physiological significance remains to be proven, because PigA is only expressed
under iron-limiting conditions, and it is presently unknown if
BphP is expressed under these conditions as well. The role of
the interaction with BphP in controlling enzymatic activity of
the two HOs and the physiological consequences of the formed
holo-BphP are subjects of continuing efforts in our laboratories.
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